Will β-blockers live up to the maxim of Sir James Black, their creator?
Department of Clinical Biochemistry, Sultan Qaboos University, Al-Khod, Muscat, Sultanate of Oman.
Khalid
K
Al-Waili
Khalid
K
Al-Rasadi
Yajnavalka
Y
Banerjee
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015994:Incidence; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D011379:Prognosis; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists